Susan R. Kahn

Active 1976–2025

142
Papers
37,452
Citations
92
h-index
139
i10-index

Citations

Citations per year for Susan R. Kahn1980: 2 citations1981: 1 citations1985: 1 citations1990: 1 citations1991: 3 citations1992: 1 citations1994: 2 citations1995: 1 citations1996: 4 citations1997: 1 citations1998: 2 citations1999: 1 citations2000: 2 citations2001: 2 citations2002: 11 citations2003: 23 citations2004: 66 citations2005: 72 citations2006: 89 citations2007: 87 citations2008: 128 citations2009: 216 citations2010: 219 citations2011: 191 citations2012: 295 citations2013: 261 citations2014: 368 citations2015: 227 citations2016: 273 citations2017: 233 citations2018: 167 citations2019: 812 citations2020: 953 citations2021: 959 citations2022: 683 citations2023: 474 citations2024: 731 citations2025: 209 citations2026: 18 citations1982–1984: no citations, so these years are not shown1986–1989: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,044 citing papers, 22.6% of this breakdownCanada: 828 citing papers, 9.2% of this breakdownUnited Kingdom: 699 citing papers, 7.7% of this breakdownItaly: 534 citing papers, 5.9% of this breakdownNetherlands: 483 citing papers, 5.4% of this breakdownChina: 441 citing papers, 4.9% of this breakdownGermany: 420 citing papers, 4.7% of this breakdownFrance: 380 citing papers, 4.2% of this breakdownSwitzerland: 262 citing papers, 2.9% of this breakdownSpain: 244 citing papers, 2.7% of this breakdownAustralia: 237 citing papers, 2.6% of this breakdownJapan: 138 citing papers, 1.5% of this breakdown
0%22.6%Other 25.7%

Fields

  • Medicine90.3%
  • Health Professions2.4%
  • Biochemistry, Genetics and Molecular Biology2.2%
  • Immunology and Microbiology1.3%
  • Engineering0.8%
  • Neuroscience0.6%
  • Other2.4%

Topics

  • Venous Thromboembolism Diagnosis and Management20.7%
  • Atrial Fibrillation Management and Outcomes7.7%
  • Blood Coagulation and Thrombosis Mechanisms5.6%
  • Diagnosis and Treatment of Venous Diseases4.7%
  • Central Venous Catheters and Hemodialysis3.4%
  • COVID-19 Clinical Research Studies3.1%
  • Other54.8%

Coauthors

All papers

Open in search
  1. Venous thromboembolism

    Authors: , , , - The Lancet 2021 cited by 708

  2. Antithrombotic Therapy for VTE Disease

    Authors: , , , , , , , , , , , - CHEST Journal 2012 cited by 6,136

  3. Prevention of VTE in Nonsurgical Patients

    Authors: , , , , , , , , , , , - CHEST Journal 2012 cited by 2,685

  4. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients

    Authors: , , , , , , , , , , , , , , , , , , - Blood Advances 2018 cited by 812

  5. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2019 cited by 594

  6. Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 852

  7. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 439

  8. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth Lorenzi, Scott Berry, Lindsay R. Berry, Aaron W. Aday, Farah Al-Beidh, Djillali Annane, Yaseen M. Arabi, Diptesh Aryal, Bihari, Shailesh, Abi Beane, Zahra Bhimani, Shailesh Bihari, Henny H. Billett, Lindsay Bond, Marc J. M. Bonten, Frank Brunkhorst, Meredith Buxton, Adrian Buzgau, Lana A. Castellucci, Sweta Chekuri, Jen‐Ting Chen, Allen Cheng, Tamta Chkhikvadze, Benjamin Coiffard, Todd W. Costantini, Sophie de Brouwer, Lennie Derde, Michelle A. Detry, Abhijit Duggal, Vladimír Džavík, Mark B. Effron, Lise J Estcourt, Brendan M. Everett, Dean Fergusson, Mark Fitzgerald, Robert Fowler, J.‐P. Galanaud, Benjamin Galen, Sheetal Gandotra, Sebastián García‐Madrona, Timothy D. Girard, Lucas C. Godoy, Andrew L. Goodman, Herman Goossens, Cameron Green, Yonatan Greenstein, Peter L Gross, Naomi M. Hamburg, Rashan Haniffa, George P. Hanna, Nicholas Hanna, Sheila M. Hegde, Carolyn M. Hendrickson, R. Duncan Hite, Alexander Hindenburg, Aluko A. Hope, James M Horowitz, Christopher M. Horvat, Kristin Hudock, Beverley J. Hunt, Mansoor Husain, Robert C. Hyzy, Vivek Iyer, Jeffrey R. Jacobson, Devachandran Jayakumar, Norma Keller, Akram Khan, Yuri Kim, Andrei Kindzelski, Andrew J. King and 78 more - 2021 cited by 589

  9. Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis

    Authors: , , , , , , , , , , , , , , - Annals of Internal Medicine 2008 cited by 847

  10. The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies

    Authors: , , , , , , , , , , - Circulation 2014 cited by 619

  11. Functional and Exercise Limitations After a First Episode of Pulmonary Embolism

    Authors: , , , , , , , , , , , , , , , - CHEST Journal 2016 cited by 275

  12. Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association

    Authors: , , , , , , , - Circulation 2020 cited by 161

  13. Pulmonary Embolism

    Authors: , - New England Journal of Medicine 2022 cited by 142

  14. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

    Authors: , , , , , , , , , , , , , - Canadian Medical Association Journal 2008 cited by 579

  15. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization

    Authors: , , , , - Journal of Thrombosis and Haemostasis 2009 cited by 508

  16. Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort

    Authors: , , , - The American Journal of Medicine 2013 cited by 468

  17. Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2019 cited by 311

  18. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study

    Authors: , , , , , , , , , , , , , , - BMJ 2017 cited by 235

  19. Epidemiology of the post-thrombotic syndrome

    Authors: , , - Thrombosis Research 2017 cited by 152

  20. Prevention and Management of the Post-Thrombotic Syndrome

    Authors: , , - Journal of Clinical Medicine 2020 cited by 104

  21. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial

    Authors: , , , , , , , , , , , , , - BMJ 2021 cited by 103

  22. Migraine Headache and Ischemic Stroke Risk: An Updated Meta-analysis

    Authors: , , , , , - The American Journal of Medicine 2010 cited by 426

  23. Long-term treatment of venous thromboembolism

    Authors: , - Blood 2020 cited by 111

  24. Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood Advances 2020 cited by 58